Key result
BNP evaluation is useful for risk stratification and tailoring therapy in chronic heart failure.
Why the study?
The usefulness of brain natriuretic peptide in evaluating cardiovascular status in children and grown-ups with congenital or acquired chronic cardiac failure was assessed.
Observational
The present study assessed the usefulness of brain natriuretic peptide in evaluating the cardiovascular status in children and grown-ups with congenital or acquired disease affected by chronic cardiac failure. Brain natriuretic peptide should be included in the risk stratification of children with dilated cardiomyopathy. In patients with congenital heart defects, it is useful to tailor the optimal medical strategy to individual patients.
No takes yet. Share an insight, caveat, or question.
Grutter et al. (2012) conducted an observational in Congenital heart defects with chronic cardiac failure. Brain natriuretic peptide (BNP) evaluation was evaluated on Cardiovascular status and risk stratification. Brain natriuretic peptide evaluation was deemed useful in evaluating cardiovascular status, risk stratification, and tailoring optimal medical strategies in patients with chronic cardiac failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: